Search Results - Gómez, Galtier
-
1
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (21-02-2019)“…Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19…”
Get full text
Journal Article -
2
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (23-11-2023)“…IntroductionTwo large multicentre European hospital networks have estimated vaccine effectiveness (VE) against COVID-19 since 2021.AimWe aimed to measure VE…”
Get full text
Journal Article -
3
Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine
Published in Influenza and other respiratory viruses (01-05-2020)“…Background Influenza A(H3N2), A(H1N1)pdm09 and B viruses co‐circulated in Europe in 2017‐18, predominated by influenza B. WHO‐recommended, trivalent vaccine…”
Get full text
Journal Article -
4
Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (16-02-2017)“…We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary…”
Get full text
Journal Article -
5
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (27-07-2017)“…We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries to measure 2015/16 influenza vaccine effectiveness (IVE)…”
Get full text
Journal Article -
6
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (01-03-2018)“…Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines)…”
Get full text
Journal Article -
7
Voyage et mémoire dans l’Antiquité romaine
Published in Viatica (Centre de recherche sur la littérature des voyages) (2021)“…Si la littérature latine n’accorde, dans l’Antiquité, qu’une place réduite à l’écriture du voyage factuel, d’ailleurs pas encore constituée en genre à part…”
Get full text
Journal Article -
8
Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform
Published in Frontiers in public health (20-07-2023)“…Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public-private partnership (PPP) that aimed to provide annual, brand-specific…”
Get full text
Journal Article -
9
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (23-11-2023)“…IntroductionThe I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since…”
Get full text
Journal Article -
10
Characteristics of a COVID-19 confirmed case series in primary care (COVID-19-PC project): a cross-sectional study
Published in BMC family practice (08-04-2021)“…To estimate the prevalence of symptoms and signs related to a COVID-19 case series confirmed by polymerase chain reaction (PCR) for SARS-CoV-2. Risk factors…”
Get full text
Journal Article